nach oben

International Urology and Nephrology

Erschienen in:

01.02.2013 | Nephrology – Original Paper

Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients

verfasst von: Tetsuri Yamashita, Kazuhiro Okano, Yuki Tsuruta, Takashi Akiba, Kosaku Nitta

Erschienen in: International Urology and Nephrology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Backgrounds

Osteocalcin (OC) is a known bone metabolic marker and a regulator of glucose and fat metabolisms. Although bone and energy metabolisms are known risk factors for cardiovascular disease (CVD) in hemodialysis (HD) patients, few studies have examined the correlation between OC and CVD. The purpose of this study was to investigate the impact of serum OC levels on the emergence of new CVD events in HD patients.

Methods

We designed a longitudinal, observational cohort study in which the study patients were divided into low- and high-serum OC groups based on a median serum OC level of 71.5 ng/ml.

Results

Cardiovascular disease events were observed in 29 of 126 patients (23.0 %). The number of cumulative CVD events in the low-serum OC group was significantly higher than that in the high-serum OC group, as evaluated by the Kaplan–Meier method (p = 0.0021, log-rank test). Multivariate Cox proportional hazards analysis demonstrated that a low level of serum OC is a significant predictor of a higher incidence of CVD events [hazard ratio, 2.925; 95 % confidence interval, 1.048–9.066; p = 0.0401] after adjustment.

Conclusion

Serum OC level is a significant, independent prognostic factor for CVD events in maintenance HD patients. OC may be useful in predicting new CVD events in HD patients.

Hauschka PV, Lian JB, Cole DE, Gundberg CM (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990–1047PubMed

Stein GS, Lian JB (1993) Molecular mechanism mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424–442PubMed

Urena P, De Vernejoul MC (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141–2156PubMedCrossRef

Malluche HH, Faugere MC, Fanti P, Price PA (1984) Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 26:869–874PubMedCrossRef

Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhan Z, Kim JK, Mauvais Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456–469PubMedCrossRef

Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates β-cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci 105:5266–5270PubMedCrossRef

Wolf G (2008) Energy regulation by the skeleton. Nutr Rev 66:229–233PubMedCrossRef

Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T (2011) Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22:187–194PubMedCrossRef

Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Norman PE (2010) Reduced serum total osteocalcin is associated with metabolic syndrome in older men through its association with hyperglycemia, waist circumference and serum triglycerides. Eur J Endocrinol 163:265–272PubMedCrossRef

10.

Rostand SG, Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383–392PubMedCrossRef

11.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218PubMedCrossRef

12.

Cunningham J, Danese M, Olson K, Klassen P, Chertow GM (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793–1800PubMedCrossRef

13.

Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CS, Whellan D, Shama K (2007) A1c and survival in maintenance hemodialysis patients. Diabetes Care 30:1049–1055PubMedCrossRef

14.

Tsujimoto Y, Ishimura E, Tahara H, Kakiya R, Koyama H, Emoto M, Shoji T, Inaba M, Kishimoto H, Tabata T, Nishizawa Y (2009) Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes. Ther Apher Dial 13:358–365PubMedCrossRef

15.

Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894–1900PubMedCrossRef

16.

Nakatsuka K, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H, Ogata E (1991) Circulating bone Gla-protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay. Contrib Nephrol 90:147–154PubMed

17.

Maseters PW, Jones RG, Purves DA, Cooper EH, Cooney JM (1994) Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 40:358–363

18.

Rached MT, Kode A, Silva BC, Jung DY, Gray S, Onq H, Paik JH, DePinho RA, Kim JK, Karsenty G, Kousteni S (2010) FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation in osteoblasts in mice. J Clin Invest 120:357–368PubMedCrossRef

19.

Blayney MJ, Pisoni RL, Bragg-Gresham JL et al (2008) High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 74:655–663PubMedCrossRef

20.

Epstein S, Traberg H, Raja R et al (1985) Serum and dialysate osteocalcin in hemodialysis and peritoneal dialysis patients and after renal transplantation. J Clin Endocrinol Metab 60:1253–1256PubMedCrossRef

21.

Yeap BB, Chubb SAP, Flicker L, McCaul KA, Ebeling PR, Hankey GJ, Beilby JP, Norman PE (2012) Associations of total with all-cause and cardiovascular mortality in older men:the health in men study. Osteoporos Int 23(2):599–606

22.

Morishita T, Nomura M, Hanaoka M, Saruta T, Matsuo T, Tsukamoto Y (2000) A new assay method that detects only intact osteocalcin. Two-step non-invasive diagnosis to predict adynamic bone disease in hemodialysed patients. Nephrol Dial Transplant 15:659–667PubMedCrossRef

23.

Frazao JM, Martins P (2009) Adynamic bone disease: clinical and therapeutic implications. Curr Opin Nephrol Hypertens 18:303–307PubMedCrossRef

24.

Price PA, Williamson MK, Lothringer JW (1981) Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Bio Chem 256:12760–12766

25.

Hwang YC, Jeong IK, Ahn KJ, Chung HY (2009) The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects. Diabetes Metab Res Rev 25:768–772PubMedCrossRef

26.

Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473–2476PubMedCrossRef

27.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134–141PubMedCrossRef

28.

Rao M, Li L, Tighiouart H (2008) Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant 23:2619–2628PubMedCrossRef

Titel: Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients
verfasst von: Tetsuri Yamashita
Kazuhiro Okano
Yuki Tsuruta
Takashi Akiba
Kosaku Nitta
Publikationsdatum: 01.02.2013
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 1/2013
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-012-0156-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients

Abstract

Backgrounds

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Ist Fasten vor Koronarinterventionen wirklich nötig?

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Backgrounds

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Secondary infertility due to use of low-dose finasteride

Podocytes proliferate: novel mechanism identified in collapsing glomerulopathies

ESRD patients using permanent vascular access report greater physical activity compared with catheter users

The effect of first dose of tamsulosin on flow rate and its predictive ability on the improvement of LUTS in men with BPH in the mid-term

β3-Adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men

Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients: a single-center experience in Turkey

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Ist Fasten vor Koronarinterventionen wirklich nötig?

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

Update Innere Medizin